Based on these genomic data, we hypothesized that restoring the p19(ARF)-MDM2-p53 tumor suppressor pathway through MDM2 inhibition would increase p53 expression and lead to apoptosis in T-ALL. This evidence concerns the gene TP53 and acute lymphoblastic leukemia.